> Details

Hum, Ryan Malcolm; Lilleker, James B; Lamb, Janine A; Oldroyd, Alexander G S; Wang, Guochun; Wedderburn, Lucy R; Diederichsen, Louise P; Schmidt, Jens; Danieli, Maria Giovanna; Oakley, Paula; Griger, Zoltan; Nguyen Thi Phuong, Thuy; Kodishala, Chanakya; Vazquez-Del Mercado, Monica; Andersson, Helena; De Paepe, Boel; De Bleecker, Jan L; Maurer, Britta; McCann, Liza; Pipitone, Nicolo; McHugh, Neil; New, Robert Paul; Ollier, William E; Krogh, Niels Steen; [...]

Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry
  • Contributor: Hum, Ryan Malcolm; Lilleker, James B; Lamb, Janine A; Oldroyd, Alexander G S; Wang, Guochun; Wedderburn, Lucy R; Diederichsen, Louise P; Schmidt, Jens; Danieli, Maria Giovanna; Oakley, Paula; Griger, Zoltan; Nguyen Thi Phuong, Thuy; Kodishala, Chanakya; Vazquez-Del Mercado, Monica; Andersson, Helena; De Paepe, Boel; De Bleecker, Jan L; Maurer, Britta; McCann, Liza; Pipitone, Nicolo; McHugh, Neil; New, Robert Paul; Ollier, William E; Krogh, Niels Steen; [...]
  • Published: Oxford University Press (OUP), 2023
  • Published in: Rheumatology (2023)
  • Language: English
  • DOI: 10.1093/rheumatology/kead481
  • ISSN: 1462-0332; 1462-0324
  • Origination:
  • Footnote:
  • Description: Abstract Objectives To compare clinical characteristics, including the frequency of cutaneous, extramuscular manifestations and malignancy, between adults with anti-synthetase syndrome (ASyS) and DM. Methods Using data regarding adults from the MYONET registry, a cohort of DM patients with anti-Mi2/-TIF1γ/-NXP2/-SAE/-MDA5 autoantibodies, and a cohort of ASyS patients with anti-tRNA synthetase autoantibodies (anti-Jo1/-PL7/-PL12/-OJ/-EJ/-Zo/-KS) were identified. Patients with DM sine dermatitis or with discordant dual autoantibody specificities were excluded. Sub-cohorts of patients with ASyS with or without skin involvement were defined based on presence of DM-type rashes (heliotrope rash, Gottron’s papules/sign, violaceous rash, shawl sign, V-sign, erythroderma, and/or periorbital rash). Results In total 1054 patients were included (DM, n = 405; ASyS, n = 649). In the ASyS cohort, 31% (n = 203) had DM-type skin involvement (ASyS-DMskin). A higher frequency of extramuscular manifestations, including Mechanic’s hands, Raynaud’s phenomenon, arthritis, interstitial lung disease and cardiac involvement differentiated ASyS-DMskin from DM (all P < 0.001), whereas higher frequency of any of four DM-type rashes—heliotrope rash (n = 248, 61% vs n = 90, 44%), violaceous rash (n = 166, 41% vs n = 57, 9%), V-sign (n = 124, 31% vs n = 28, 4%), and shawl sign (n = 133, 33% vs n = 18, 3%)—differentiated DM from ASyS-DMskin (all P < 0.005). Cancer-associated myositis (CAM) was more frequent in DM (n = 67, 17%) compared with ASyS (n = 21, 3%) and ASyS-DMskin (n = 7, 3%) cohorts (both P < 0.001). Conclusion DM-type rashes are frequent in patients with ASyS; however, distinct clinical manifestations differentiate these patients from classical DM. Skin involvement in ASyS does not necessitate increased malignancy surveillance. These findings will inform future ASyS classification criteria and patient management.